BeiGene, Ltd. anticipated opening of biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.2 USD | -1.75% | -4.24% | -18.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.92% | 15.31B | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.22% | 22.48B | |
-9.86% | 18.32B | |
-42.28% | 16.33B | |
+6.19% | 14.08B | |
+28.83% | 11.74B | |
+80.51% | 9.02B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024